Breast cancer drug Kadcyla now offered on NHS

[News]

In a major move, Kadcyla, a breast cancer drug that could prolong life expectancy and disease free survival among breast cancer patients is to be offered on NHS as a result of a deal between the health service and Pharmaceutical company Roche.

More... (http://www.news-medical.net/news/20170615/Breast-cancer-drug-Kadcyla-now-offered-on-NHS.aspx)